DEUTSCHE BANK AG\

Bank

Position in CCCC — C4 Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in CCCC

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$461,736

+$387,776 QoQ

Shares Held

98,873

+113.9% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 147 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. CCCC ranks #182 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$461,736	98,873	+113.9%	Shares	Defined	2026-08-07
2025-03-31	$73,960	46,225	+18.0%	Shares	Defined	2025-05-09
2024-09-30	$223,326	39,180	+31.3%	Shares	Defined	2025-06-26
2024-06-30	$137,897	29,848	+15.1%	Shares	Defined	2025-06-12
2023-03-31	$81,425	25,932	+45.9%	Shares	Defined	2023-05-15
2022-12-31	$104,843	17,770	+1.6%	Shares	Defined	2023-02-13
2022-09-30	$153,378	17,489	-5.1%	Shares	Defined	2022-11-14
2022-06-30	$138,947	18,428	-31.7%	Shares	Defined	2022-08-11
2022-03-31	$654,776	26,990	-51.8%	Shares	Defined	2022-05-13
2021-12-31	$1,804,487	56,040	+131.7%	Shares	Defined	2022-02-16
2021-09-30	$1,080,629	24,186	+10.6%	Shares	Defined	2021-11-04
2021-06-30	$827,143	21,859	+203.0%	Shares	Defined	2021-08-11
2021-03-31	$266,845	7,214	-8.2%	Shares	Defined	2021-05-13
2020-12-31	$260,467	7,862	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.